匹地利珠单抗
Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$800.00
Member price
Product Availability
3-5days
Price
$2300.00
Member price
Product Availability
3-5days
Price
$4200.00
Member price
Product Availability
3-5days
Price
$18500.00
Member price
Product Availability
3-5days
Price
$34000.00
Member price
Quantity
- +
Product Overview
Product Name Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
CAS1036730-42-3
Security information
Product details

Pidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.

Related literature
Related
Sorry, no related items
History
Ado-trastuzumab Emtansine (TDM-1)
Robatumumab (Anti-IGF1R / CD221)
Urelumab (Anti-TNFRSF9 / 4-1BB / CD137)
Lebrikizumab (Anti-IL-13)
Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
Pinatuzumab (Anti-Siglec-2 / CD22)
Emibetuzumab (Anti-HGFR / c-Met)
Tildrakizumab (Anti-IL-23a)
Olokizumab (Anti-IL-6 / IFNb2)
Brodalumab (anti-IL17RA)